Item 9 Labs Corp. (INLB)
INLB Stock Price Chart
Explore Item 9 Labs Corp. interactive price chart. Choose custom timeframes to analyze INLB price movements and trends.
INLB Company Profile
Discover essential business fundamentals and corporate details for Item 9 Labs Corp. (INLB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Jan 2012
Employees
97.00
Website
https://www.item9labscorp.comCEO
Jeffrey I. Rassas
Description
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
INLB Financial Timeline
Browse a chronological timeline of Item 9 Labs Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 18 Nov 2024
Earnings released on 9 Aug 2024
Earnings released on 31 May 2024
Earnings released on 12 Feb 2024
Earnings released on 29 Nov 2023
Earnings released on 21 Aug 2023
EPS came in at -$0.06 falling short of the estimated -$0.03 by -100.00%, while revenue for the quarter reached $5.02M , beating expectations by +11.61%.
Earnings released on 22 May 2023
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $5.66M , beating expectations by +25.84%.
Earnings released on 14 Feb 2023
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $5.00M , beating expectations by +11.20%.
Earnings released on 13 Jan 2023
EPS came in at -$0.08 falling short of the estimated -$0.02 by -400.00%, while revenue for the quarter reached $4.00M , beating expectations by +0.04%.
Earnings released on 15 Aug 2022
EPS came in at -$0.06 falling short of the estimated -$0.03 by -100.00%, while revenue for the quarter reached $4.93M , missing expectations by -29.55%.
Earnings released on 16 May 2022
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $6.64M , missing expectations by -9.07%.
Earnings released on 14 Feb 2022
EPS came in at -$0.04 matching the estimated -$0.04, while revenue for the quarter reached $6.19M , missing expectations by -0.23%.
Earnings released on 18 Jan 2022
EPS came in at -$0.11 , while revenue for the quarter reached $6.09M .
Earnings released on 16 Aug 2021
EPS came in at -$0.01 , while revenue for the quarter reached $6.69M .
Earnings released on 17 May 2021
EPS came in at $0.00 , while revenue for the quarter reached $6.11M .
Earnings released on 16 Feb 2021
EPS came in at -$0.02 , while revenue for the quarter reached $3.04M .
Earnings released on 29 Oct 2020
EPS came in at -$0.12 , while revenue for the quarter reached $2.52M .
INLB Stock Performance
Access detailed INLB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.